Archive: February 2026
Feature
Practice Tips From the Updated Helicobacter pylori Treatment Guidelines
Abstract: In 2024, the American College of Gastroenterology released updated guidelines for managing Helicobacter pylori infection, replacing the previous 2017 guidelines. Since that time, 3 new […]
Feature
Redefining Early Intervention and the Window of Opportunity in Crohn’s Disease
Abstract: Crohn’s disease is a chronic, progressive inflammatory bowel condition characterized by unpredictable episodes of flare and remission. Inflammation that is not controlled, and even in […]
MASH in Focus
Sarcopenia in Patients With MASLD/MASH
G&H How can metabolic dysfunction-associated steatotic liver disease, including metabolic dysfunction-associated steatohepatitis, lead to sarcopenia, or the depletion of muscle mass? JL Patients with metabolic dysfunction-associated […]
Advances in IBD
Inflammatory Bowel Disease and Eosinophilic Esophagitis
G&H Do patients with inflammatory bowel disease have a higher risk of eosinophilic esophagitis? EB Several single-center studies have shown that patients with inflammatory bowel disease […]
Advances in Endoscopy
Management of Perforation During Polypectomy
G&H What is the risk of polypectomy-related perforation depending on location (especially colon vs duodenum)? GR It is important to appreciate the thickness of the mucosal […]
Letter From the Editor
Letter From the Editor: The Evolving Concept of a Therapeutic Window of Opportunity for Crohn’s Disease
What is the therapeutic window of opportunity in patients with Crohn’s disease? This question is explored in a feature article in this month’s issue of Gastroenterology […]